{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:28:04Z","timestamp":1788424084034,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012464","name":"Kaleida Health Foundation","doi-asserted-by":"publisher","award":["IHS-1507-31640"],"award-info":[{"award-number":["IHS-1507-31640"]}],"id":[{"id":"10.13039\/100012464","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-12619-7","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:36:08Z","timestamp":1744263368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Considerations for equitable distribution of digital healthcare for people who use drugs"],"prefix":"10.1186","volume":"25","author":[{"given":"Zoi","family":"Papalamprakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Ntagianta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kalamitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vana","family":"Sypsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Hatzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Talal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"12619_CR1","doi-asserted-by":"publisher","first-page":"108684","DOI":"10.1016\/j.jsat.2021.108684","volume":"137","author":"EJ Austin","year":"2022","unstructured":"Austin EJ, Tsui JI, Barry MP, Tung E, Glick SN, Ninburg M, et al. Health care-seeking experiences for people who inject drugs with hepatitis C: qualitative explorations of stigma. J Subst Abuse Treat. 2022;137:108684.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"12619_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.14892","volume":"115","author":"D Lewer","year":"2020","unstructured":"Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ, et al. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction. 2020;115(6):1011\u201323.","journal-title":"Addiction"},{"issue":"9","key":"12619_CR3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/09540121.2020.1826396","volume":"33","author":"S Dasgupta","year":"2021","unstructured":"Dasgupta S, Tie Y, Lemons-Lyn A, Broz D, Buchacz K, Shouse RL. HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services. AIDS Care. 2021;33(9):1146\u201354.","journal-title":"AIDS Care"},{"issue":"Suppl 5","key":"12619_CR4","doi-asserted-by":"publisher","first-page":"S420","DOI":"10.1093\/infdis\/jiaa337","volume":"222","author":"R Lewis","year":"2020","unstructured":"Lewis R, Baugher AR, Finlayson T, Wejnert C, Sionean C, National HIV Behavioral Surveillance (NHBS) Study Group. Healthcare access and utilization among persons who inject drugs in medicaid expansion and nonexpansion States: 22 United States cities, 2018. J Infect Dis. 2020;222(Suppl 5):S420\u20138.","journal-title":"J Infect Dis"},{"key":"12619_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"44","key":"12619_CR6","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.3748\/wjg.v19.i44.7846","volume":"19","author":"M Zeremski","year":"2013","unstructured":"Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol. 2013;19(44):7846\u201351.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"12619_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","volume":"77","author":"S Larney","year":"2020","unstructured":"Larney S, Tran LT, Leung J, Santo T Jr., Santomauro D, Hickman M, et al. All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis. JAMA Psychiatry. 2020;77(5):493\u2013502.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"12619_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2468-1253(23)00018-3","volume":"8","author":"A Artenie","year":"2023","unstructured":"Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):533\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12619_CR9","doi-asserted-by":"publisher","first-page":"100177","DOI":"10.1016\/j.lanepe.2021.100177","volume":"8","author":"S Popping","year":"2021","unstructured":"Popping S, Kall M, Nichols BE, Stempher E, Versteegh L, van de Vijver D, et al. Quality of life among people living with HIV in England and the Netherlands: a population-based study. Lancet Reg Health Eur. 2021;8:100177.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"12619_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000500963","volume":"35","author":"L Sandmann","year":"2019","unstructured":"Sandmann L, Schulte B, Manns MP, Maasoumy B. Treatment of chronic hepatitis C: efficacy, side effects and complications. Visc Med. 2019;35(3):161\u201370.","journal-title":"Visc Med"},{"issue":"6","key":"12619_CR11","doi-asserted-by":"publisher","first-page":"ofac181","DOI":"10.1093\/ofid\/ofac181","volume":"9","author":"N Nagot","year":"2022","unstructured":"Nagot N, D\u2019Ottavi M, Quillet C, Debellefontaine A, Castellani J, Langendorfer N, et al. Reaching hard-to-reach people who use drugs: a community-based strategy for the elimination of hepatitis C. Open Forum Infect Dis. 2022;9(6):ofac181.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"12619_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13012-019-0861-y","volume":"14","author":"EN Woodward","year":"2019","unstructured":"Woodward EN, Matthieu MM, Uchendu US, Rogal S, Kirchner JE. The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment. Implement Sci. 2019;14(1):26.","journal-title":"Implement Sci"},{"key":"12619_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev-publhealth-090519-093711","volume":"42","author":"W Barbosa","year":"2021","unstructured":"Barbosa W, Zhou K, Waddell E, Myers T, Dorsey ER. Improving access to care: telemedicine across medical domains. Annu Rev Public Health. 2021;42:463\u201381.","journal-title":"Annu Rev Public Health"},{"issue":"7","key":"12619_CR14","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1089\/tmj.2023.0632","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Pe\u00f1a MT, Lal LS, Lin Y-Y, Summers RL, Chandra S, et al. Telemental health services usage and association with health care utilization and expenditures among vulnerable medicare beneficiaries in 2019: a comparative study using propensity score matching. Telemed E Health. 2024;30(7):1848\u201356.","journal-title":"Telemed E Health"},{"key":"12619_CR15","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.technovation.2022.102547","volume":"120","author":"P Baudier","year":"2023","unstructured":"Baudier P, Kondrateva G, Ammi C, Chang V, Schiavone F. Digital transformation of healthcare during the COVID-19 pandemic: patients\u2019 teleconsultation acceptance and trusting beliefs. Technovation. 2023;120:102547.","journal-title":"Technovation"},{"key":"12619_CR16","doi-asserted-by":"publisher","first-page":"103570","DOI":"10.1016\/j.drugpo.2021.103570","volume":"101","author":"A Sivakumar","year":"2022","unstructured":"Sivakumar A, Madden L, DiDomizio E, Eller A, Villanueva M, Altice FL. Treatment of hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: the potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Int J Drug Policy. 2022;101:103570.","journal-title":"Int J Drug Policy"},{"issue":"9","key":"12619_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11920-021-01274-4","volume":"23","author":"SA Saeed","year":"2021","unstructured":"Saeed SA, Masters RM. Disparities in health care and the digital divide. Curr Psychiatry Rep. 2021;23(9):61.","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"12619_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12911-023-02194-4","volume":"23","author":"M Haimi","year":"2023","unstructured":"Haimi M. The tragic Paradoxical effect of telemedicine on healthcare disparities\u2014a time for redemption: a narrative review. BMC Med Inf Decis Mak. 2023;23(1):95.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"12619_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12954-023-00861-3","volume":"20","author":"TS Bartholomew","year":"2023","unstructured":"Bartholomew TS, Tookes HE, Chueng TA, Bluthenthal RN, Wenger LD, Kral AH, et al. Availability of telehealth-based services at syringe services programs under the COVID-19 public health emergency. Harm Reduct J. 2023;20(1):122.","journal-title":"Harm Reduct J"},{"issue":"1","key":"12619_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/07853890.2023.2182908","volume":"55","author":"E Suarez Jr","year":"2023","unstructured":"Suarez E Jr., Bartholomew TS, Plesons M, Ciraldo K, Ostrer L, Serota DP, et al. Adaptation of the tele-harm reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study. Ann Med. 2023;55(1):733\u201343.","journal-title":"Ann Med"},{"key":"12619_CR21","doi-asserted-by":"publisher","first-page":"109124","DOI":"10.1016\/j.drugalcdep.2021.109124","volume":"229","author":"HE Tookes","year":"2021","unstructured":"Tookes HE, Bartholomew TS, Suarez E, Ekowo E, Ginoza M, Forrest DW, et al. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs. Drug Alcohol Depend. 2021;229:109124.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"12619_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","volume":"16","author":"CL Cooper","year":"2017","unstructured":"Cooper CL, Hatashita H, Corsi DJ, Parmar P, Corrin R, Garber G. Direct-Acting antiviral therapy outcomes in Canadian chronic hepatitis C telemedicine patients. Ann Hepatol. 2017;16(6):874\u201380.","journal-title":"Ann Hepatol"},{"key":"12619_CR23","unstructured":"Health Resources and Services, Administration H. How do I use telehealth for behavioral health care? 2025. Available from: https:\/\/telehealth.hhs.gov\/patients\/additional-resources\/telehealth-and-behavioral-health#:~:text=Telehealth%20can%20be%20used%20to,Medication%2Dassisted%20treatment."},{"issue":"2","key":"12619_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/ciy899","volume":"69","author":"AH Talal","year":"2019","unstructured":"Talal AH, Andrews P, McLeod A, Chen Y, Sylvester C, Markatou M, et al. Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone. Clin Infect Dis. 2019;69(2):323\u201331.","journal-title":"Clin Infect Dis"},{"issue":"16","key":"12619_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jama.2024.2452","volume":"331","author":"AH Talal","year":"2024","unstructured":"Talal AH, Markatou M, Liu A, Perumalswami PV, Dinani AM, Tobin JN, et al. Integrated hepatitis C\u2013opioid use disorder care through facilitated telemedicine: a randomized trial. JAMA. 2024;331(16):1369\u201378.","journal-title":"JAMA"},{"issue":"9","key":"12619_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/tmj.2018.0161","volume":"25","author":"AH Talal","year":"2019","unstructured":"Talal AH, McLeod A, Andrews P, Nieves-McGrath H, Chen Y, Reynolds A, et al. Patient reaction to telemedicine for clinical management of hepatitis C virus integrated into an opioid treatment program. Telemed J E Health. 2019;25(9):791\u2013801.","journal-title":"Telemed J E Health"},{"issue":"3","key":"12619_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1089\/tmj.2022.0189","volume":"29","author":"AH Talal","year":"2023","unstructured":"Talal AH, Sofikitou EM, Wang K, Dickerson S, Jaanim\u00e4gi U, Markatou M. High satisfaction with patient-centered telemedicine for hepatitis C virus delivered to substance users: a mixed-methods study. Telemed J E Health. 2023;29(3):395\u2013407.","journal-title":"Telemed J E Health"},{"key":"12619_CR28","doi-asserted-by":"publisher","first-page":"108272","DOI":"10.1016\/j.jsat.2020.108272","volume":"124","author":"L Wang","year":"2021","unstructured":"Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. J Subst Abuse Treat. 2021;124:108272.","journal-title":"J Subst Abuse Treat"},{"key":"12619_CR29","first-page":"3488","volume":"2020","author":"JT Lai","year":"2020","unstructured":"Lai JT, Chapman BP, Carreiro SP, Costigan AD, Rodriguez-Perez KM, Gonzalez G, et al. A pilot study of a telemedicine-based substance use disorder evaluation to enhance access to treatment following near-fatal opioid overdose. Proc Annu Hawaii Int Conf Syst Sci. 2020;2020:3488\u201396.","journal-title":"Proc Annu Hawaii Int Conf Syst Sci"},{"issue":"8","key":"12619_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1089\/tmj.2021.0127","volume":"27","author":"CS Adams","year":"2021","unstructured":"Adams CS, Player MS, Berini CR, Perkins S, Fay J, Walker L, et al. A telehealth initiative to overcome health care barriers for people experiencing homelessness. Telemed J E Health. 2021;27(8):851\u20138.","journal-title":"Telemed J E Health"},{"issue":"1","key":"12619_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12911-022-01952-0","volume":"22","author":"R Ftouni","year":"2022","unstructured":"Ftouni R, AlJardali B, Hamdanieh M, Ftouni L, Salem N. Challenges of telemedicine during the COVID-19 pandemic: a systematic review. BMC Med Inf Decis Mak. 2022;22(1):207.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"4","key":"12619_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/10550887.2022.2035166","volume":"40","author":"S Delisle-Reda","year":"2022","unstructured":"Delisle-Reda S, Bruneau J, Martel-Laferri\u00e8re V. Telehealth for people who inject drugs: an acceptable method of treatment but challenging to access. J Addict Dis. 2022;40(4):514\u20137.","journal-title":"J Addict Dis"},{"key":"12619_CR33","doi-asserted-by":"publisher","first-page":"104356","DOI":"10.1016\/j.drugpo.2024.104356","volume":"126","author":"S Roussos","year":"2024","unstructured":"Roussos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, et al. High levels of all-cause mortality among people who inject drugs from 2018 to 2022. Int J Drug Policy. 2024;126:104356.","journal-title":"Int J Drug Policy"},{"key":"12619_CR34","unstructured":"World Health Organization. Universal health coverage. 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/universal-health-coverage-(uhc)#:~:text=Overview,products%2C%20and%20enjoying%20decent%20work."},{"issue":"1","key":"12619_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12913-021-06678-9","volume":"21","author":"T Myloneros","year":"2021","unstructured":"Myloneros T, Sakellariou D. The effectiveness of primary health care reforms in Greece towards achieving universal health coverage: a scoping review. BMC Health Serv Res. 2021;21(1):628.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"12619_CR36","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/add.12999","volume":"110","author":"A Hatzakis","year":"2015","unstructured":"Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015;110(9):1453\u201367.","journal-title":"Addiction"},{"key":"12619_CR37","doi-asserted-by":"publisher","first-page":"106632","DOI":"10.1016\/j.cct.2021.106632","volume":"112","author":"AH Talal","year":"2022","unstructured":"Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, et al. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: telemedicine for evaluation, adherence and medication for hepatitis C (TEAM-C). Contemp Clin Trials. 2022;112:106632.","journal-title":"Contemp Clin Trials"},{"key":"12619_CR38","unstructured":"Eurostat. Digital economy and society statistics - households and individuals. 2023. Available from: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Digital_economy_and_society_statistics_-_households_and_individuals."},{"key":"12619_CR39","unstructured":"European Patients Forum. Access to healthcare. EPF\u2019s survey-final report. 2016. Available from: https:\/\/www.eu-patient.eu\/globalassets\/policy\/access\/final-access-survey-report_16-dec.pdf."},{"issue":"2","key":"12619_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399.","journal-title":"Soc Probl"},{"issue":"1","key":"12619_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1525\/sp.2002.49.1.11","volume":"49","author":"DD Heckathorn","year":"2014","unstructured":"Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2014;49(1):11\u201334.","journal-title":"Soc Probl"},{"issue":"2","key":"12619_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/jvh.13437","volume":"28","author":"SN Kapadia","year":"2021","unstructured":"Kapadia SN, Katzman C, Fong C, Eckhardt BJ, Guarino H, Mateu-Gelabert P. Hepatitis C testing and treatment uptake among young people who use opioids in new York City: a cross-sectional study. J Viral Hepat. 2021;28(2):326\u201333.","journal-title":"J Viral Hepat"},{"issue":"1","key":"12619_CR43","first-page":"79","volume":"24","author":"E Volz","year":"2008","unstructured":"Volz E, Heckathorn DD. Probability-based estimation theory for respondent-driven sampling. J Off Stat. 2008;24(1):79.","journal-title":"J Off Stat"},{"issue":"1","key":"12619_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1536867X1201200106","volume":"12","author":"M Schonlau","year":"2012","unstructured":"Schonlau M, Liebau E. Respondent-driven sampling. Stata J. 2012;12(1):72\u201393.","journal-title":"Stata J"},{"issue":"3","key":"12619_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1370\/afm.2095","volume":"15","author":"RE Powell","year":"2017","unstructured":"Powell RE, Henstenburg JM, Cooper G, Hollander JE, Rising KL. Patient perceptions of telehealth primary care video visits. Ann Fam Med. 2017;15(3):225\u20139.","journal-title":"Ann Fam Med"},{"issue":"1","key":"12619_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11606-020-06201-6","volume":"36","author":"D Motavalli","year":"2021","unstructured":"Motavalli D, Taylor JL, Childs E, Valente PK, Salhaney P, Olson J, et al. \u201cHealth is on the back burner:\u201d multilevel barriers and facilitators to primary care among people who inject drugs. J Gen Intern Med. 2021;36(1):129\u201337.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"12619_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09540121.2013.819403","volume":"26","author":"LM Sagrestano","year":"2014","unstructured":"Sagrestano LM, Clay J, Finerman R, Gooch J, Rapino M. Transportation vulnerability as a barrier to service utilization for HIV-positive individuals. AIDS Care. 2014;26(3):314\u20139.","journal-title":"AIDS Care"},{"key":"12619_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2018.07.006","volume":"93","author":"S Amiri","year":"2018","unstructured":"Amiri S, Lutz R, Soc\u00edas ME, McDonell MG, Roll JM, Amram O. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County, Washington. J Subst Abuse Treat. 2018;93:26\u201330.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"12619_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12954-024-00961-8","volume":"21","author":"C Scaramutti","year":"2024","unstructured":"Scaramutti C, Hervera B, Rivera Y, Chueng TA, Forrest DW, Suarez E, et al. Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma. Harm Reduct J. 2024;21(1):50.","journal-title":"Harm Reduct J"},{"issue":"12","key":"12619_CR50","doi-asserted-by":"publisher","first-page":"e0208410","DOI":"10.1371\/journal.pone.0208410","volume":"13","author":"R Abadie","year":"2018","unstructured":"Abadie R, Goldenberg S, Welch-Lazoritz M, Fisher CB. Establishing trust in HIV\/HCV research among people who inject drugs (PWID): insights from empirical research. PLoS ONE. 2018;13(12):e0208410.","journal-title":"PLoS ONE"},{"issue":"1","key":"12619_CR51","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12911-024-02718-6","volume":"24","author":"Z Papalamprakopoulou","year":"2024","unstructured":"Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson SS, et al. Telehealth to increase healthcare access: perspectives of people who use drugs. BMC Med Inf Decis Mak. 2024;24(1):306.","journal-title":"BMC Med Inf Decis Mak"},{"key":"12619_CR52","first-page":"236","volume":"275","author":"C Mimigiannis","year":"2020","unstructured":"Mimigiannis C, Gallos P, Mantas J. The drug addicts\u2019 usage of information and communication technologies. Stud Health Technol Inf. 2020;275:236\u20137.","journal-title":"Stud Health Technol Inf"},{"issue":"3","key":"12619_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/10550887.2011.581989","volume":"30","author":"SP Novak","year":"2011","unstructured":"Novak SP, Kral AH. Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the united States. J Addict Dis. 2011;30(3):248\u201357.","journal-title":"J Addict Dis"},{"issue":"1","key":"12619_CR54","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/08897077.2021.1975871","volume":"43","author":"JE Ozga","year":"2022","unstructured":"Ozga JE, Paquette C, Syvertsen JL, Pollini RA. Mobile phone and internet use among people who inject drugs: implications for mobile health interventions. Subst Abus. 2022;43(1):592\u20137.","journal-title":"Subst Abus"},{"key":"12619_CR55","doi-asserted-by":"crossref","unstructured":"Patanwala MY, Garcia CM, Kushel M. Health care for people experiencing homelessness. JAMA. 2024;2024;332(1):70\u201371.","DOI":"10.1001\/jama.2024.5213"},{"issue":"4","key":"12619_CR56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/08897077.2016.1176980","volume":"37","author":"KM Collins","year":"2016","unstructured":"Collins KM, Armenta RF, Cuevas-Mota J, Liu L, Strathdee SA, Garfein RS. Factors associated with patterns of mobile technology use among persons who inject drugs. Subst Abus. 2016;37(4):606\u201312.","journal-title":"Subst Abus"},{"key":"12619_CR57","doi-asserted-by":"crossref","unstructured":"Roussos S, Paraskevis D, Psichogiou M, Kostaki EG, Flountzi E, Angelopoulos T, et al. Ongoing HIV transmission following a large outbreak among people who inject drugs in Athens, Greece (2014\u201320). Addiction. 2022;117(6):1670-82.","DOI":"10.1111\/add.15812"},{"key":"12619_CR58","unstructured":"Center for Behavioral Health Statistics and Quality. 2016 national survey on drug use and health: detailed tables. Rockville: Subst Abuse Ment Health Serv Adm. 2017."},{"key":"12619_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/RMHP.S70173","volume":"8","author":"K Hacker","year":"2015","unstructured":"Hacker K, Anies M, Folb BL, Zallman L. Barriers to health care for undocumented immigrants: a literature review. Risk Manag Healthc Policy. 2015;8:175\u201383.","journal-title":"Risk Manag Healthc Policy"},{"key":"12619_CR60","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/JMDH.S104807","volume":"9","author":"A Althubaiti","year":"2016","unstructured":"Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016;9:211\u20137.","journal-title":"J Multidiscip Healthc"},{"issue":"5","key":"12619_CR61","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2468-2667(21)00013-X","volume":"6","author":"C Arum","year":"2021","unstructured":"Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health. 2021;6(5):e309-23.","journal-title":"Lancet Public Health"},{"issue":"11","key":"12619_CR62","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jamainternmed.2021.5450","volume":"181","author":"SD Halpern","year":"2021","unstructured":"Halpern SD, Chowdhury M, Bayes B, Cooney E, Hitsman BL, Schnoll RA, et al. Effectiveness and ethics of incentives for research participation: 2 randomized clinical trials. JAMA Intern Med. 2021;181(11):1479\u201388.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"12619_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11524-006-9052-7","volume":"83","author":"AS Abdul-Quader","year":"2006","unstructured":"Abdul-Quader AS, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Sabin K, et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health. 2006;83(3):459\u201376.","journal-title":"J Urban Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12619-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12619-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12619-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T18:03:55Z","timestamp":1744308235000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-12619-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12619"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12619-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.19.24312251","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Boards of the Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases and the University at Buffalo. The study adhered to the Helsinki Declaration principles. We obtained written informed consent from all study eligible participants prior to their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.H.T. received grants from Merck, Gilead, and Abbott Laboratories and has served as an advisor at Gilead, Novo Nordisk, and AbbVie. VS has received grants from Gilead and AbbVie paid to affiliated institutions, and she has served as a lecturer for Gilead and AbbVie. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}